Founded in 1979, Immuno-Mycologics (IMMY) manufactures biotechnology fungal diagnostics, saving lives in over 80 countries.
Having a lab with the functionality of running PCR tests, IMMY found themselves at the epicenter of the Covid-19 pandemic. The area hospitals requested their help in running PCR tests and administering vaccines.
IMMY tasked their developers to create a Health Insurance Portability and Accountability Act (HIPAA) compliant SaaS/COTS to manage the influx of PCR testing and the results. The software handled the demands by:
ü Processing over 6,400 PCR tests in a single day,
ü Returning patient results in an average of 14 hours,
ü Administering 10,000 vaccines in 12 hours at one single location.
The software saved the users and patients an extraordinary amount of time. Because it was so effective, the Oklahoma State Department of Health (OSDH) sent a letter to IMMY requesting to purchase the software to use across the entire state.
Therefore, IMMY created a new company, Immy Technology Group (ITG), LLC, in August of 2021, and ITG commercially launched their new platform called Streamline. A little over three years later, ITG’s Streamline platform consists of a Lab Request Portal, an Occupational Health System, an Electronic Health Record System (EHR), an Immunization Information System, and a Laboratory Information Management System. With almost limitless functionality, Streamline’s platforms empower customers to configure and tailor solutions to their specifications.
ITG is currently a very small company with five full-time employees. We would like to break into the federal marketplace by subcontracting with a larger company on federal efforts. We are in the process of obtaining our HUBZone certification which we hope will open more opportunities for us.
We prefer to partner with like-minded companies where our capabilities compliment theirs to make a strong solution for the Government.
